These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 923250)

  • 21. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate.
    Furuhjelm M; Carlström K
    Acta Obstet Gynecol Scand; 1977; 56(4):351-61. PubMed ID: 602703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term effects of depot-medroxyprogesterone acetate on lipoprotein metabolism.
    Garza-Flores J; De la Cruz DL; Valles de Bourges V; Sanchez-Nuncio R; Martinez M; Fuziwara JL; Pérez-Palacios G
    Contraception; 1991 Jul; 44(1):61-71. PubMed ID: 1832626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative studies of the ethynyl estrogens used in oral contraceptives. VI. Effects with and without progestational agents on carbohydrate metabolism in humans, baboons, and beagles.
    Goldzieher JW; Chenault CB; De La Pena A; Dozier TS; Kraemer DC
    Fertil Steril; 1978 Aug; 30(2):146-53. PubMed ID: 98357
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
    Zaki K; Sami G; Nour H
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaginal bleeding disturbances associated with the discontinuation of long-acting injectable contraceptives. From the World Health Organization Special Programme for Research, Development, and Research Training in Human Reproduction; Task Force on Long-acting Systemic Agents for the Regulation of Fertility.
    Gray RH; Parker RA; Diethelm P
    Br J Obstet Gynaecol; 1981 Mar; 88(3):317-21. PubMed ID: 7008825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of fertility with oral medication.
    Diddle AW; Watts GF; Gardner WH; Williamson PJ
    West J Surg Obstet Gynecol; 1964; 72():222-9. PubMed ID: 12305556
    [TBL] [Abstract][Full Text] [Related]  

  • 27. On the mechanism of action of progestins.
    Pérez-Palacios G; Fernández-Aparicio MA; Medina M; Zacarías-Villareal J; Ulloa-Aguirre A
    Acta Endocrinol (Copenh); 1981 Jul; 97(3):320-8. PubMed ID: 6455041
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of norethindrone acetate released from a single silastic implant on serum FSH, LH, progesterone and estradiol-17beta of women during first eight months of treatment.
    Rahman SA; Jha P; Laumas V; Jain AK; Dileepkumar ; Takkar D; Hingorani V; Laumas KR
    Contraception; 1977 Nov; 16(5):487-97. PubMed ID: 590011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
    Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
    J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Return of fertility in women discontinuing injectable contraceptives.
    Fotherby K; Howard G
    J Obstet Gynaecol (Lahore); 1986 Apr; 6 Suppl 2():S110-5. PubMed ID: 12315276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levels of contraceptive seroids in breast milk and plasma of lactating women.
    Saxena BN; Shrimanker K; Grudzinskas JG
    Contraception; 1977 Dec; 16(6):605-13. PubMed ID: 606500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The contraceptive efficacy of 10mg or 25mg of norethindrone given orally on day 15-22 of the human menstrual cycle.
    Nygren KG; Johansson ED; Wide L
    Contraception; 1974 Mar; 9(3):249-56. PubMed ID: 4442274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin sensitivity is decreased in normal women by doses of ethinyl estradiol used in oral contraceptives.
    Kojima T; Lindheim SR; Duffy DM; Vijod MA; Stanczyk FZ; Lobo RA
    Am J Obstet Gynecol; 1993 Dec; 169(6):1540-4. PubMed ID: 8267059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma levels of norethisterone after single and multiple injections of norethisterone oenanthate.
    Fotherby K; Howard G; Shrimanker K; Elder M; Bye PG
    Contraception; 1978 Jul; 18(1):1-6. PubMed ID: 679682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum lipids and lipoproteins during treatment with oral contraceptives containing natural and synthetic oestrogens. A controlled double-blind investigation.
    Bostofte E; Hemmingsen L; Møller KJ; Serup J; Weber T
    Acta Endocrinol (Copenh); 1978 Apr; 87(4):855-64. PubMed ID: 347855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver function tests in patients on oral progestogens.
    Engineer AD; Gupta V; Tandon P
    J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum norethindrone (NET) concentrations following intramuscular NET enanthate injection. Effect upon serum LH, FSH, estradiol and progesterone.
    Goebelsmann U; Stanczyk FZ; Brenner PF; Goebelsmann AE; Gentzschein EK; Mishell DR
    Contraception; 1979 Mar; 19(3):283-313. PubMed ID: 572279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report.
    Contraception; 1983 Jul; 28(1):1-20. PubMed ID: 6226488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sustained effects on synthetic ovarian steroids of rat myometrial contractility.
    Parkington HC; Lipton A
    J Endocrinol; 1976 Aug; 70(2):223-7. PubMed ID: 965882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Some metabolic and hormonal changes in women using long acting injectable contraceptives.
    Abdel-sayed WS; Toppozada HK; Said SA; El-sayed OK
    Alex J Pharm Sci; 1989 Mar; 3(1):29-32. PubMed ID: 12316139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.